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Abstract Enthoprotin, a newly identi¢ed component of clath-
rin-coated vesicles, interacts with the trans-Golgi network
(TGN) clathrin adapters AP-1 and GGA2. Here we perform
a multi-faceted analysis of the site in enthoprotin that is respon-
sible for the binding to the Q-adaptin ear (Q-ear) domain of
AP-1. Alanine scan mutagenesis and nuclear magnetic reso-
nance (NMR) studies reveal the full extent of the site as well
as critical residues for this interaction. NMR studies of the
Q-ear in complex with a synthetic peptide from enthoprotin pro-
vide structural details of the binding site for TGN accessory
proteins within the Q-ear.
) 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
Internalization via clathrin-coated pits and clathrin-coated
vesicles (CCVs) constitutes the major route of endocytic entry
into cells [1]. Central to this process is the clathrin adapter
protein 2 (AP-2), a heterotetramer composed of K-, L2-, W2-,
and c2-adaptins [2]. At the trans-Golgi network (TGN),
CCVs mediate the transport of cargo proteins from the secre-
tory pathway to the endosomal/lysosomal system [3]. This
event is regulated by the heterotetrameric AP-1 complex, com-
posed of Q-, L1-, W1-, and c1-adaptins [4]. A family of mono-
meric clathrin adapters that are functionally related to AP-1
and AP-2, the Golgi-localized, Q-ear-containing, Arf-binding
proteins (GGA1^3), have also been described at the TGN/
endosome [5,6].
At their C-termini, L-, K-, Q-adaptins and GGAs contain
globular structures termed ‘ear’ domains. The structure of
the K-ear has been determined at 1.4 AD resolution and is
composed of a proximal L-sandwich domain and a distal
mixed K-L platform domain [7,8]. The K-ear serves as a pro-
tein sca¡old that allows AP-2 to recruit a diverse array of
endocytic accessory proteins to sites of CCV formation
[9,10]. These proteins bind to the K-ear through three short
yet distinct consensus peptide motifs, DPF/W, FXDXF, and
WVQF [7,8,11,12]. The structures of the Q-ear and the GGA
ear (GAE domain) have also been solved [13,14]. These do-
mains have nearly identical folds and are structurally con-
served with the L-sandwich domain of the K-ear [13^15]. Anal-
ogous to the K-ear, the Q-ear and the GAE domain function to
recruit accessory proteins to clathrin bud sites [3]. However,
the subset of accessory proteins that interact with the Q-ear
and the GAE domain at the TGN and endosome, and the
peptide motifs mediating these interactions, are distinct from
those observed for the K-ear [3].
Using a proteomic analysis of CCVs, we recently identi¢ed
enthoprotin, a novel AP-1- and GGA2-binding partner [16].
Enthoprotin was independently identi¢ed and termed Clint
[17] and epsinR [18,19]. At its N-terminus, enthoprotin con-
tains an epsin N-terminal homology (ENTH) domain. The
ENTH domain mediates interactions with phospholipids and
proteins and is found primarily in proteins that function in
clathrin-mediated endocytosis [20,21]. However, enthoprotin
is unique among known ENTH domain-containing proteins
in mammals in that it functions in clathrin-mediated budding
at the TGN [16^19].
The binding of enthoprotin to AP-1 and GGA2 is mediated
via the Q-ear and the GAE domain, respectively [16^19]. Re-
cently, two sequences of di¡ering a⁄nity have been identi¢ed
as Q-ear-binding sites within enthoprotin [19]. The high-a⁄nity
site (site 2) has also been reported to interact with the GAE
domain of GGA3 [22]. However, neither of these sites has
been characterized in detail. In this study, we perform a bio-
chemical analysis of enthoprotin site 2 and characterize its
interactions with the Q-ear. These data provide new insights
into enthoprotin/adapter interactions and an important mo-
lecular characterization of the Q-ear/GAE domain-binding
motif in enthoprotin.
2. Materials and methods
2.1. Antibodies and recombinant constructs
Antibodies against the Flag epitope and green £uorescent protein
(GFP) were from Sigma and Santa Cruz Biotechnology, respectively.
Glutathione S-transferase (GST)-Q-ear (amino acids 704^822) of
mouse Q-adaptin was generated by polymerase chain reaction (PCR)
from the I.M.A.G.E. clone 1265666 and was cloned into pGEX-2T
(Amersham Biosciences). cDNA KIAA0171 was used as a template
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for PCR to generate Flag-tagged human enthoprotin constructs in
pFlag-CMV-2 (Sigma). Deletion mutants lacking amino acids 342^
351 (site 1) and 369^378 (site 2) were generated by two rounds of
PCR as described [23]. Full-length Flag-tagged enthoprotin and GST-
rat epsin ENTH domain were previously described [16,24]. GFP-
Eps15 construct was a generous gift of Dr. Pier Paolo Di Fiore (Euro-
pean Institute of Oncology, Milan, Italy).
2.2. Alanine scan mutagenesis
To generate alkaline phosphatase (AP)^peptide fusion proteins,
double-stranded oligonucleotides encoding wild-type or mutant pep-
tides, corresponding to enthoprotin amino acids 367^379, were cloned
into the pEZ707 vector (Z. Han and B.K. Kay, unpublished) at the N-
terminus of the mature enzyme. Fusion proteins were expressed in the
BL21(DE3) Escherichia coli strain. Levels of fusion proteins in crude
bacterial extracts were normalized based on AP activity and were
serially diluted in Nunc Maxisorp plates (Nalge Nunc International)
previously coated with GST-Q-ear (200 ng/well) and blocked with 1%
bovine serum albumin. The plates were incubated for 1 h at room
temperature and then washed with phosphate-bu¡ered saline/0.05%
Tween 20. Bound AP fusion proteins were revealed by a colorimetric
reaction using paranitrophenyl phosphate.
2.3. GST pull-down assays and peptide competition binding assays
Transfected HEK-293 cells were scraped in bu¡er A (10 mM
HEPES-OH, pH 7.4, protease inhibitors) or bu¡er B (25 mM Tris^
HCl, pH 7.4, 150 mM NaCl, 0.5 mM EDTA, protease inhibitors),
sonicated and brought to 1% in Triton X-100. Triton X-100-soluble
extracts (0.2^1 mg) were incubated for 2 h at 4‡C with GST fusion
proteins bound to glutathione-Sepharose (Amersham Biosciences).
Samples were then washed in appropriate bu¡er containing 1% Triton
X-100, and speci¢cally bound proteins were processed for Western
blot analysis. Peptide competition experiments were performed as de-
scribed above except that approximately 0.2 nmol of GST fusion
protein was pre-incubated with synthetic peptides (synaptojanin
1-ANPFPSLPTRNPFTDRTAAPGNPFR or enthoprotin site 2-NG-
DFGDWSAF, containing an N-terminal cysteine residue, produced at
the Yale University W.M. Keck Facility) prior to addition of cell
lysate.
2.4. Nuclear magnetic resonance (NMR) spectroscopy
Mouse Q-ear was transferred from pGEX-2T into pGEX-2TK and
expressed in E. coli BL21 (Gold) strain. Cultures were grown at 37‡C
in M9 medium supplemented with 15N ammonium chloride and 13C-
enriched glucose to produce uniformly 15N- or 15N,13C-labeled pro-
teins. Following a 6 h induction with 1 mM isopropyl-L-D-thiogalac-
tose at 25‡C, GST-Q-ear was puri¢ed and cleaved with thrombin. The
NMR samples contained 0.3^1.6 mM protein in bu¡er C (90% H2O/
10% D2O, 50 mM sodium phosphate, pH 7.2, 150 mM NaCl, 0.5 mM
EDTA and 3 mM dithiothreitol).
NMR spectra were acquired at 30‡C on a Bruker DRX-600 spec-
trometer equipped with triple resonance probes and pulsed ¢eld gra-
dients. The following 3D experiments were used for backbone and
side chain 1H, 13C and 15N resonance assignments: HNCACB,
CBCA(CO)HN, HNCO, 15N-edited NOESY (with mixing time of
90 ms) and 15N-edited TOCSY [25]. The NMR assignments have
been deposited in the BioMagnetic Resonance Bank database under
BMRB accession number 5761 (www.bmrb.wisc.edu). Detailed anal-
ysis of peptide binding to the protein was carried out by comparison
of chemical shifts for backbone amide signals in 1H-15N HSQC spec-
tra. HSQC spectra were recorded at 1:4, 1:2, 1:1 and 2:1 peptide to
protein ratios that were con¢rmed by UV concentration of both com-
Fig. 1. Mutational analysis of enthoprotin Q-ear-binding site 2. A: Cell lysates containing Flag-tagged enthoprotin (residues 1^451) or residues
1^451 lacking site 1 (vsite 1) or site 2 (vsite 2) were incubated with GST, GST-Q-ear, or GST-terminal domain of the clathrin heavy chain
(GST-TD) coupled to glutathione-Sepharose. Speci¢cally bound proteins were processed for Western blot (WB) with anti-Flag antibody. An ali-
quot of the cell lysate (starting material, SM) was processed in parallel. B: A peptide comprising site 2 fused to AP was incubated at increasing
concentrations with GST, GST-Q-ear, or GST-epsin ENTH domain immobilized on microtiter plates. Speci¢cally bound peptide was detected
through AP enzymatic activity, expressed as optical density (OD) at 405 nm wavelength. C: AP alone (control) or AP fused to peptides with
the indicated sequences (mutated amino acids are in bold) was incubated with GST-Q-ear immobilized on microtiter plates. Speci¢c binding was
detected through AP enzymatic activity and expressed as a percentage of activity seen with the wild-type peptide. Bars represent the meanV
S.E.M. of four to six individual experiments performed in triplicate.
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ponents and intensity of HO1 (Trp) signals in 1D-NMR. Color ¢gures
were generated by the GRASP program [26], and structural data were
taken from Protein Data Bank entry 1GYU [15].
A sequence encoding residues 359^388 from enthoprotin was sub-
cloned into the pGEX-6P-1 vector and expressed as a 15N-labeled
GST fusion peptide in the E. coli BL21 (Gold) strain. For NMR
studies, the peptide was cleaved with PreScission Protease (Amersham
Biosciences), puri¢ed by reverse-phase chromatography on a C-18
column (Vydac), lyophilized, and resuspended in bu¡er C at pH
6.5. The 15N-edited NOESY (mixing time of 200 ms) and 15N-edited
TOCSY experiments were used for the assignment of amide signals in
the 15N-1H HSQC spectra at 30‡C. NMR titrations of the 15N-labeled
peptide by the unlabeled Q-ear protein were performed as described
above. Due to strong broadening of some HSQC signals of the pep-
tide in complex with Q-ear (region between S18 and A23), chemical
shift changes were measured for a 1:5 protein to peptide ratio and
recalculated for a 1:1 complex.
3. Results
Synthetic 12-amino acid peptides encoding two putative
Q-ear-binding sites in enthoprotin were previously shown to
bind with di¡ering a⁄nities to the Q-ear [19]. To demonstrate
that these sequences are important in the context of the pro-
tein, we generated enthoprotin constructs lacking these sites.
Deletion of site 1 (amino acids 344^353) had no noticeable
e¡ect on the binding of enthoprotin to Q-ear whereas deletion
of site 2 (amino acids 369^378) led to a signi¢cant decrease in
binding compared to wild-type protein (Fig. 1A). All con-
structs were equally expressed and bound comparably to a
GST fusion protein of the clathrin terminal domain (Fig.
1A). These data con¢rm that site 2, which matches the
high-a⁄nity site described by Mills et al. [19], is the major
Q-ear-binding site in enthoprotin.
To examine the contribution to Q-ear interaction of individ-
ual amino acids within site 2, we performed an alanine scan
analysis. Wild-type or mutant forms of a site 2 peptide were
fused to AP and incubated with puri¢ed GST-Q-ear in micro-
titer plates. As expected, the wild-type peptide bound in a
dose-dependent, saturable manner to the Q-ear but not to
GST or a GST-epsin ENTH construct (Fig. 1B). The alanine
scan revealed that three of the mutations (N369A, G370A and
S376A) had no e¡ect or led to increased binding (Fig. 1C). In
contrast, ¢ve alanine mutations (D371A, F372A, D374A,
W375A, and F378A) signi¢cantly reduced binding (Fig. 1C).
Mutation of G373 to A only slightly reduced Q-ear binding,
whereas G373R strongly inhibited the interaction (Fig. 1C).
These data reveal amino acids within enthoprotin site 2 crit-
ical for Q-ear binding.
We next used NMR studies to explore enthoprotin/Q-ear
interactions at a structural level. Comparison of 1H-15N
HSQC spectra of a 15N-labeled 30-amino acid enthoprotin
peptide encompassing site 2, in the absence or presence of
the Q-ear domain, revealed multiple chemical shift changes,
indicative of conformational changes in the amino acids
caused by Q-ear interactions (Fig. 2 and data not shown).
The most signi¢cant changes (0.1^0.3 ppm) correspond to
Fig. 2. Mapping of enthoprotin residues involved in binding to the Q-ear. A: 15N-1H HSQC spectrum of the 15N-labeled 30-amino acid entho-
protin peptide with signal assignments. B: Magnitude of the amide chemical shift changes ({(v1H shift)2+(v15N shiftU0.2)2}1=2 in ppm) of the
15N-labeled 30-amino acid enthoprotin peptide recorded upon binding of the unlabeled Q-ear.
Fig. 3. Eps15 and enthoprotin share an overlapping binding site on
the Q-ear. A: Alignment of enthoprotin site 2 with related sequences
from various Q-ear-binding proteins. The amino acid number of the
¢rst residue is shown. The shading indicates the most frequent ami-
no acids used at any given position and the asterisks denote amino
acids in enthoprotin site 2 shown through mutational analysis to de-
crease binding to Q-ear. B: Lysates from cells transfected with either
Flag-tagged full-length enthoprotin (Flag-EP) or GFP-tagged Eps15
were incubated with GST-Q-ear fusion protein. A peptide encoding
enthoprotin site 2 (EP site 2) or a control peptide from synaptoja-
nin (Sj) was added to the binding assays at the indicated molar ra-
tios of peptide to fusion protein. Speci¢cally bound proteins were
processed for Western blotting with anti-Flag and anti-GFP anti-
bodies.
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residues DFGDWSAFNQ (Fig. 2B). This sequence comprises
all the amino acids that are critical for Q-ear binding, as
mapped by mutagenesis (Fig. 1C). These data reveal the
boundaries of the Q-ear-binding site in enthoprotin.
In addition to enthoprotin, a number of mammalian pro-
teins have been shown to bind to the Q-ear including Q-syner-
gin [27], rabaptin-5 [28], and Eps15 [15]. Each of these pro-
teins contains one or more putative Q-ear/GAE domain-
binding sequences related to that in enthoprotin (Fig. 3A).
The presence of these sequences suggests that these proteins
could occupy the same binding site on the Q-ear and could
thus compete with enthoprotin for Q-ear binding. We used
Eps15 to test this hypothesis. A peptide encompassing site 2
from enthoprotin (369-NGDFGDWSAF-378) competed the
binding of both Flag-enthoprotin and GFP-Eps15 to GST-Q-
ear (Fig. 3B). Neither of the proteins was competed by a
control peptide from synaptojanin-170 (Sj peptide), encoding
three copies of the NPF tripeptide [29] (Fig. 3B). Thus, Eps15
and enthoprotin share an overlapping binding site on the
Q-ear. This suggests that, as for binding of endocytic accessory
factors to the AP-2 K-ear, multiple components of the bud-
ding machinery at the TGN and endosome compete for bind-
ing to a shared site on the Q-ear.
The structure of the Q-ear has been recently solved by X-ray
crystallography [13,15]. To explore the accessory protein-bind-
ing site on the Q-ear at the structural level, we performed a
NMR analysis of the Q-ear in the presence of the site 2 peptide
from enthoprotin. Comparison of 1H-15N HSQC spectra of
Fig. 4. Structural analysis of Q-ear-binding motif interactions with Q-ear. A: Comparison of 1H-15N HSQC spectra of the 15N-labeled Q-ear in
the absence (black) or presence (red) of the site 2 peptide CNGDFGDWSAF (1:2 peptide to protein ratio). Peaks for two protons of amide
groups in Asn and Gln side chains are connected. B: Magnitude of the amide chemical shift changes in ppm of the Q-ear upon binding of the
site 2 peptide (1:1 complex). The positions of L-strands are shown. The indicated residue numbers correspond to mouse Q-adaptin. C: The
backbone trace of the Q-ear is colored according to the size of the amide chemical shift changes upon binding of the site 2 peptide (red,
vNs svNs 0.1; and white vN6 0.1 ppm). Residues showing the largest chemical shift changes are labeled. D: A partial sequence of the mouse
Q-ear is shown with L-strands and K-helices depicted as arrows and rods, respectively. Red and yellow shading represents chemical shift changes
as indicated in C. Asterisks mark residues that, when mutated, a¡ect binding to Q-synergin [13,15].
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the 15N-labeled Q-ear, in the absence or presence of the site 2
peptide, revealed multiple chemical shift changes indicative of
conformational changes in the amino acids caused by peptide
interactions (Fig. 4A). The magnitudes of the amide chemical
shift changes were plotted throughout the length of the Q-ear
construct and revealed an e¡ect primarily on residues in
L-sheets 4, 5, and 7, with a smaller in£uence on residues in
L-sheet 8 (Fig. 4B). The most extensive shifts were plotted
over the crystal structure of the Q-ear revealing a face on the
Q-ear, composed of L-sheets 4, 5, 7, and 8, as the binding site
for enthoprotin (Fig. 4C).
4. Discussion
A conserved 5^6-amino acid sequence present in several
AP-1- and GGA-binding proteins has been identi¢ed to me-
diate the interaction with the Q-ear and the GAE domain (Fig.
3A) [14,19,27,28,30]. Alignment of this sequence has led to the
prediction of a consensus Q-ear/GAE domain-binding motif,
which is mainly composed of hydrophobic and acidic residues
(reviewed in [31]). A strong conservation of the amino acids
present at positions 31, 0, +2, and +3 (Fig. 3A) suggests that
these residues may be important for Q-ear interactions. Here,
we have systematically tested this prediction. Alanine scan
analysis demonstrates that for enthoprotin, D371^W375
form the core of the Q-ear-binding motif. A strong reduction
in binding was seen with mutation of the two aromatic resi-
dues F372 and W375 to A. F372 in enthoprotin is the only
amino acid that is conserved amongst all of the known and
putative ear-binding sites (position 0) (Fig. 3A) [31,32].
Although the W is found only in enthoprotin site 2, all other
sequences contain a hydrophobic residue at position +3, with
F being the most frequent. Given that W375A showed re-
duced binding and that the L that occupies this position in
rabaptin-5 is also necessary for binding [28], it appears that a
bulky hydrophobic residue at position +3 is important for ear
domain interactions. Within most sequences, the amino acid
that follows the invariant F at position 0 is either G or A (Fig.
3A). This position is occupied by G373 in enthoprotin site 2.
G373A slightly decreased Q-ear binding, showing that alanine
residues are not optimal, but are tolerated at this position.
Mutation of G373 to R strongly reduced binding, suggesting
that a small side chain is necessary in this position to be
permissive for binding.
A notable observation was that F378A had a strong e¡ect
on Q-ear interactions. Moreover, in NMR experiments, F378
was seen to undergo a strong shift change upon binding to the
Q-ear. Thus, the F appears to be important for the stability of
enthoprotin site 2 interactions with the Q-ear, demonstrating
that the Q-ear-binding motif extends C-terminal to the con-
served core sequence. The position at +6 has not been pre-
dicted to be part of the Q-ear/GAE domain-binding motif
[19,31]. Interestingly, co-crystallization of the GGA3-GAE
domain with a peptide encompassing the GAE domain-bind-
ing site from rabaptin-5 revealed that the alanine residue at
position +6 makes contact with residues situated at the end of
the L5 strand [22]. In NMR experiments, we observe a strong
shift change in the corresponding area of the Q-ear upon en-
thoprotin peptide binding. Therefore, it is interesting to spec-
ulate that variability at position +6 may be one of the deter-
minants that confer speci¢city to the interactions of di¡erent
accessory proteins with the Q-ear and the GAE domains.
Two recent studies used X-ray crystallography to determine
the structure of the GAE domain of GGA1 and GGA3 in
complex with peptides from p56 (DDDDFGGFEAAETFD)
and rabaptin-5 (DESDFGPLVGADS), respectively [22,32].
However, no structural data have been available on the inter-
actions of the Q-ear with its ligands. Based on mutational
analysis, Kent and colleagues [15] proposed that the ligand-
binding site in the Q-ear is composed of a shallow trough
formed where L-sheets 4 and 5 meet and they demonstrated
that A753 in L-sheet 4, L762 in L-sheet 5 and P765 in the L5/
L6 loop, which also lies within the L4/L5 trough, contribute to
Q-synergin binding. On the other hand, Nogi and colleagues
[13] proposed that ligand binding to Q-ear is mediated by a
basic surface comprised of amino acids R793, R795, and
K797 in L-sheet 7 and K756 in L-sheet 4. NMR analysis of
the Q-ear in complex with the enthoprotin site 2 peptide re-
veals that the binding site is composed of residues within
L-sheets 4, 5, 7, and 8 that align on one face of the Q-ear
(Fig. 4C).
In general, the NMR results reported here are consistent
with the previous mutational analyses on the Q-ear as well as
with the crystallographic analysis of the GAE domains in
complex with their ligands [13,15,22,32] (Fig. 4D). Of the
seven residues that demonstrate the largest chemical shift
changes, four of them, A752, V754, M794 and I796, have
their side chains oriented inside the Q-ear L-sandwich (Fig.
4D). However, based on the general geometrical structure of
L-sheets, it is reasonable to propose that the observed NMR
changes for these backbone amide groups are accounted for
by steric contacts with the side chains of preceding amino
acids. Thus, Q751, A753, R793, and R795, which each have
side chains that are oriented into solution, may interact with
the enthoprotin peptide directly (Fig. 4D). Large chemical
shift changes were also seen for K756, L763, and S764, which
all have side chains in solution that could contribute to ligand
binding. Previously, Mills et al. [19] demonstrated that L762
in the Q-ear is necessary for binding to enthoprotin and sim-
ilarly, we have observed that a GST-Q-ear L762E construct
fails to bind endogenous enthoprotin (data not shown). The
lack of a chemical shift change for L762 in the NMR analysis
reported here (Fig. 4D) does not exclude that L762 is con-
tacted by ligand as its chemical shift change could be com-
pensated by a steric contact with the side chain of Q761.
Thus, NMR analysis coupled with mutational studies has
provided a complementary view of the enthoprotin-binding
site within the Q-ear. Detailed analysis of the Q-ear/GAE do-
main-binding motif sequences in TGN accessory proteins in-
cluding enthoprotin will lead to a better understanding of the
selectivity that underlies the formation of protein networks at
the TGN and endosomes.
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